Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia.


The transcription factor encoded by the E-twenty-six (ETS)-related gene, ERG, is an essential regulator of hematopoietic stem cell function and a potent human oncoprotein. Enforced expression of ERG in murine hematopoietic cells leads to the development of a well-characterized lymphoid leukemia and a less well-defined non lymphoid disease. To clarify the latter, we generated murine bone marrow chimeras with enforced Erg expression in engrafted hematopoietic progenitor cells. As expected, these mice developed lymphoid leukemia. However, the previously reported non lymphoid disease that developed was shown to be a uniform, transplantable leukemia with both erythroid and megakaryocytic characteristics. In vivo, this disease had the overall appearance of an erythroleukemia, with an accumulation of immature erythroblasts that infiltrated the bone marrow, spleen, liver, and lung. However, when stimulated in vitro, leukemic cell clones exhibited both erythroid and megakaryocytic differentiation, suggesting that transformation occurred in a bipotential progenitor. Thus, in mice, Erg overexpression induces the development of not only lymphoid leukemia but also erythro-megakaryocytic leukemia.

3 Figures and Tables

Citations per Year

448 Citations

Semantic Scholar estimates that this publication has 448 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Carmichael2012HematopoieticOO, title={Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia.}, author={Catherine Louise Carmichael and Donald Metcalf and Katya J. Henley and Elizabeth A. Kruse and Ladina Di Rago and Sandra L Mifsud and Warren S. Alexander and Benjamin T Kile}, journal={Proceedings of the National Academy of Sciences of the United States of America}, year={2012}, volume={109 38}, pages={15437-42} }